Table 3.
Patient characteristics and clinical outcomes comparing study participants who lost at least 5% of their body weight to those that did not.
| <5% weight change (n = 32) | >5% weight change (n = 14) | p-value | |
|---|---|---|---|
| Gender (% males) | 75.0 | 78.6 | 1.00 |
| Age (years) (IQR) | 57.0 (20.0) | 56.5 (9) | 0.98 |
| Change in BMI (IQR) | −0.7 (1.5) | −2.3 (0.6) | <0.01 |
| Change in weight (kg) (IQR) | −2.0 (3.9) | −7.1 (1.7) | <0.01 |
| Change in percent body weight (IQR) | −1.9 (4.1) | −7.5 (1.5) | <0.01 |
| Change in HbA1c (IQR) | −0.0 (0.5) | −0.2 (0.3) | 0.21 |
| Change in total cholesterol (mg/dl) (IQR) | −8.5 (45) | −2.5 (30) | 0.69 |
| Change in HDL (mg/dl) (IQR) | −1.0 (9.7) | 3.1 (8.9) | 0.23 |
| Change in LDL (mg/dl) (IQR) | −3.5 (41.8) | 4.0 (35.0) | 0.19 |
| Change in triglyceride (mg/dl) (IQR) | −4.5 (45.5) | −54 (54) | <0.01 |
| Change in fibrosis (kPA) (IQR) | 0.1 (2.2) | −1.2 (3.1) | 0.04 |
| Change in controlled attenuation parameter (dB/m) (IQR) | 23.5 (72.0) | −65.5 (92) | <0.01 |
| Ethnicity (%) | |||
| White (n = 19) | 43.8% | 35.7% | 0.46 |
| African American (n = 15) | 34.4% | 28.6% | |
| Hispanic (n = 11) | 21.9% | 28.6% | |
| Asian (n = 1) | 0.0% | 7.1% |
Significant p-values are bolded.